BGENE-DMD is designed to treat Duchenne muscular dystrophy (DMD) via a one-time administration in a single AAV.

Ipsen, a global specialty care biopharmaceutical company, has made the following changes to its Executive Committee: ...

Sygnature Discovery has completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory infrastructure.

Crown Bioscience’s San Diego laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification.

Operational strategies to optimize efficiency and cost effectiveness, and secure an unbroken chain of custody from ...

Roquette, a provider of plant-based ingredients and pharmaceutical excipients, has launched POLYOX Extended Stability (ES) packaging.